Attached files
file | filename |
---|---|
EX-32 - ABEONA THERAPEUTICS INC. | ex32.htm |
EX-31.2 - ABEONA THERAPEUTICS INC. | ex31-2.htm |
EX-31.1 - ABEONA THERAPEUTICS INC. | ex31-1.htm |
EX-21 - ABEONA THERAPEUTICS INC. | ex21.htm |
10-K - ABEONA THERAPEUTICS INC. | form10-k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements No. 333-197220 on Form S-1, Nos. 333-204179, 333-205128 and 333-224867 on Form S-3, and Nos. 333-125796, 333-161642, 333-169067, 333-189985, 333-204055, 333-214846, 333-221552 and 333-238571 on Form S-8 Abeona Therapeutics Inc. and Subsidiaries, of our report dated March 24, 2021, relating to the consolidated financial statements appearing in this Annual Report on Form 10-K of Abeona Therapeutics Inc. and Subsidiaries for the year ended December 31, 2020.
/s/ WHITLEY PENN LLP
Plano, Texas
March 24, 2021